Abstract 15549: Adult Congenital Heart Disease as a Risk Modifier After Atrial Fibrillation Ablation: A Propensity Matched Analysis
Abstract
Background: Catheter ablation is increasingly used for rhythm control in adults with congenital heart disease (ACHD) and atrial fibrillation (AF). However, contemporary data comparing post-ablation outcomes between ACHD and non-ACHD populations remain limited. We evaluated cardiovascular, arrhythmic, and procedural outcomes following AF ablation in a large real-world cohort. Methods: Adults with AF who underwent catheter ablation between 2015 and 2024 were identified in the TriNetX Research Network. Cohort 1 included those with ACHD (n = 10,785), while cohort 2 included those without a history of ACHD (n = 120.738). Propensity score matching (1:1) was performed using 47 demographic, clinical, laboratory, healthcare utilization, and medication variables, including anticoagulant and antiarrhythmic therapies. Outcomes were assessed between 90 and 365 days following ablation using Kaplan-Meier and Cox proportional hazards analyses. The matched cohort included 10,771 ACHD patients and 10,771 non-ACHD patients. Results: After propensity matching, baseline characteristics were well balanced. Compared with non-ACHD patients, ACHD patients experienced higher rates of AF recurrence (55.1% vs 52.0%, HR 1.04; 95% CI 1.01-1.08; P=0.024), 3-point MACE (4.0% vs 2.8%, HR 1.41; 95% CI 1.19-1.66; P=0.013), acute myocardial infarction (1.8% vs 1.4%, HR 1.28; 95% CI 1.02-1.62; P=0.007), heart failure hospitalization (7.1% vs 5.5%, HR 1.26; 95% CI 1.13-1.40; P<0.001), supraventricular tachycardia (6.0% vs 4.3%, HR 1.36; 95% CI 1.17-1.57; P<0.001), ventricular tachycardia/fibrillation (3.4% vs 2.4%, HR 1.35; 95% CI 1.13-1.61; P=0.015), cardioversion (3.9% vs 2.1%, HR 1.81; 95% CI 1.46-2.24; P<0.001), and repeat ablation (7.6% vs 6.3%, HR 1.18; 95% CI 1.07-1.31; P=0.001). No significant differences were observed in all-cause mortality (1.8% vs 1.7%, HR 1.03; 95% CI 0.84-1.26; P=0.929). Conclusions: Despite comprehensive adjustment for baseline characteristics, ACHD was associated with consistently worse post-ablation cardiovascular, arrhythmic, and procedural outcomes. The increased burden of recurrent arrhythmias, repeat interventions, heart failure hospitalization, and adverse cardiovascular events suggests that ACHD remains an important risk modifier following AF ablation and may warrant enhanced long-term surveillance and tailored management strategies.